Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response.
Mathias Rummel(Universitätsklinikum Gießen und Marburg), Wolfram Brugger(University of Freiburg), Martina Stauch, Christina Balser(Philipps University of Marburg), Gamal-Andre Banat(Justus-Liebig-Universität Gießen), Ulrich Kaiser(University of Applied Sciences Landshut), Georg Maschmeyer(Radboud University Medical Center), Dorothea Kofahl-Krause(Medizinische Hochschule Hannover), Fritz Roller(Justus-Liebig-Universität Gießen), Chrisoph Losem, Axel Hinke, N. Niederle(Klinikum Leverkusen), Harald Balló(Praxis für Hämatologie und Onkologie), Juergen Barth(Justus-Liebig-Universität Gießen), Eckhart Weidmann(Krankenhaus Nordwest), Manfred Welslau(Klinikum Aschaffenburg), Gerhard Heil(Goethe University Frankfurt), Ulrich von Grünhagen(Praxis für Hämatologie und Onkologie), Heinz A. Duerk, Alexander Burchardt(Johannes Gutenberg University Mainz)
Cited by 2
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k